Multiplex qPCR assay for discrimination and qualitative detection of RNA from SARS-CoV-2 (ORF1ab and S gene targets), Influenza A, Influenza B and RSV A&B. With discrimination between these 4 winter pathogens in conjunction with an extremely high level of clinical sensitivity, this IVD provides the ideal flexible solution for total control, specifically designed for winter 2020/21.

• Highly sensitive for all targets (each target ≤ 1 copy/ul)
• 96 tests
• Validated against CFX (Bio-Rad), ABI 7500 (Applied Biosystems) and LC480 II (Roche)
• Master mix included
• Traceability of values assigned to calibrating of control materials. Assured through reference measurement procedures
• Comprehensive validation in concordance with ISO13485. Post-market maintenance of technical files, including strain information
• Total kit performance measurement and assurance provided
• Open platform chemistry, with calibration panel available for instruments requiring colour compensation (Roche LC480 II)